Treatment Updates

published November 6, 2023
Are you living (or caring for someone) with Chronic Lymphocytic Leukaemia or Small Lymphocytic Leukaemia? A g
published August 5, 2021
Eligible patients can now access Yescarta through Royal Brisbane and Women’s Hospital, Brisbane and the Pete
published March 30, 2021
IMPORTANT Information for all Lymphoma/ CLL Australian patients receiving MabThera® (rituximab)   From
published November 30, 2020
The combination of VENCLEXTA plus obinutuzumab will be available as a fixed duration therapy for previously un

Contact Lymphoma Australia Today!

Please note:
Lymphoma Australia staff are only able to reply to emails sent in English language.

Newsletter Sign Up

Useful Definitions

  • Refractory: This means the lymphoma does not get better with treatment. The treatment didn’t work as hoped.
  • Relapsed: This means the lymphoma came back after being gone for a while after treatment.
  • 2nd line treatment: This is the second treatment you get if the first one didn’t work (refractory) or if the lymphoma comes back (relapse).
  • 3rd line treatment: This is the third treatment you get if the second one didn’t work or the lymphoma comes back again.
  • Approved: Available in Australia and listed by the Therapeutics Goods Administration (TGA).
  • Funded: Costs are covered for Australian citizens. This means if you have a Medicare card, you shouldn’t have to pay for the treatment.[WO7]

You need healthy T-cells to make CAR T-cells. For this reason, CAR T-cell therapy cannot be used if you have a T-cell lymphoma – yet.

For more information on CAR T-cells and T-cell lymphoma click here. 

Special Note: Although your T-cells are removed from your blood for CAR T-cell therapy, most of our T-cells live outside of our blood – in our lymph nodes, thymus, spleen and other organs.